XML 27 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings per Share
3 Months Ended
Mar. 31, 2018
Earnings Per Share [Abstract]  
Earnings per Share
Earnings per Share
The computations of basic and diluted EPS are set forth below:
 
For the Three Months Ended March 31,
 
2018
 
2017
 
 
(in thousands, except per share  amounts, unaudited)
Numerator for basic and diluted EPS — net income (loss)
$
6,368

 
$
(746
)
 
Denominator for basic EPS — weighted average number of shares
29,755

 
31,904

 
Add — dilutive effect of:
 
 
 
 
Restricted stock units
444

(1)

(2)
Denominator for diluted EPS — weighted average number of shares and dilutive securities
30,199

 
31,904

 
Earnings (loss) per share:
 
 
 
 
Basic EPS
$
0.21

 
$
(0.02
)
 
Diluted EPS
$
0.21

 
$
(0.02
)
 

The weighted number of shares and dilutive potential shares do not include 334,048 shares of common stock, which will be issued to certain selling unitholders of Cogent, following the fourth anniversary of the acquisition if the revenue target related to the Earnout is achieved. In the event that the revenue target is achieved, such shares will be included in the Company’s share count in the period the revenue target is achieved. If the revenue target is not achieved, such shares of common stock will not be issued. See "Note 4 — Fair Value of Financial Instruments".
________________________
(1) Excludes the incremental shares that would be issued if the treasury stock method was applied to 1,255,997 outstanding restricted stock units that were antidilutive for the three months ended March 31, 2018, and thus were not included in the above calculation. The incremental shares that could be included in the diluted EPS calculation in future periods will vary based on a variety of factors, including the future share price and the amount of unrecognized compensation cost. The incremental shares included, if any, would be less than the number of outstanding restricted stock units.
(2) Excludes the incremental shares that would be issued if the treasury stock method was applied to 2,722,509 outstanding restricted stock units that were antidilutive for the three months ended March 31, 2017, and thus were not included in the above calculation. The incremental shares that could be included in the diluted EPS calculation in future periods will vary based on a variety of factors, including the future share price and the amount of unrecognized compensation cost. The incremental shares included, if any, would be less than the number of outstanding restricted stock units.